No problem! But I would have another question. Why does another company write about a drug from Multicell in the past? The next question would be the drug of Multicell in the market? But nobody knows because it should be kept secret???
MultiCell Technologies Phase IIB licenced candidate LAX-202 in a major deal worth USD 275 million in milestone payments and royalties.http://cyxone.com/en/newsletter-july-2017/